MARC details
000 -LEADER |
fixed length control field |
02196cam a2200325 a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
EG-GiCUC |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
140918s2013 ua dh f m 000 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
EG-GiCUC |
Language of cataloging |
eng |
Transcribing agency |
EG-GiCUC |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
Deposite |
097 ## - Thesis Degree |
Thesis Level |
Ph.D |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
Classification number |
Cai01.11.07.Ph.D.2013.Al.Q |
100 0# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Alaa Amr Gad |
245 10 - TITLE STATEMENT |
Title |
Quantitative RT-PCR study of TAp73 and xNp73 in benign and malignant lymphoid lesions / |
Statement of responsibility, etc. |
Alaa Amr Gad ; Supervised Hoda Ali Sadek , Laila Abdalrahman Hegazy , Mona Salah Aldin Hamdy |
246 15 - VARYING FORM OF TITLE |
Title proper/short title |
في تضخم الغدد اللمفاوية الحميدة والخبييثة RT-PCRباستخدام TAp73 و xNp73 دراسة لكمية |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Cairo : |
Name of publisher, distributor, etc. |
Alaa Amr Gad , |
Date of publication, distribution, etc. |
2013 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
210 P. : |
Other physical details |
charts , facsimiles ; |
Dimensions |
25cm |
502 ## - DISSERTATION NOTE |
Dissertation note |
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Background: p73 is a member of the p53 family of tumor suppressors. Transactivating isoforms of p73 (TAp73) have p53-like, anti-proliferative and pro-apoptotic activities that are crucial for an efficient chemotherapy response. However, in contrast to p53, which is commonly inactivated in human cancer by point mutations, the TP73 gene is almost never mutated. Instead, the tumor suppressor activity of TAp73 is inhibited through a variety of mechanisms including epigenetic silencing and complex formation with inhibitory proteins. All these mechanisms have in common that they are in principle reversible and therefore amenable to therapeutic intervention. The use of 2 promoters at the N-terminus allows the expression of an isoform containing (TAp73) or not containing (xNp73) a complete N terminal transactivation domain, with the latter isoform capable of a dominant negative effect over the former |
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
Additional physical form available note |
Issued also as CD |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Benign and Malignant Lymphoid Lesions |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
RT-PCR |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
TAp73 and xNp73 |
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Hoda Ali Sadek , |
Relator term |
|
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Laila Abdalrahman Hegazy , |
Relator term |
|
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Mona Salah Aldin Hamdy , |
Relator term |
|
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
Cataloger |
Aml |
Reviser |
Cataloger |
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
Cataloger |
Nazla |
Reviser |
Revisor |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Thesis |